a month ago
CKPT
AnalystsMayank MamtaniMayank Mamtani's Stock Forecasts
AnalystsMayank Mamtani
Sectors:
Industries:
Analyst Ranking
Top 1%
#25 out of 4166 analysts
Average Return
+54.17%
Win Rate
53%30 out of 57
Risk vs Reward
Poor
Good
Mayank Mamtani's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Novavax IncNVAX | +1,295.56% | $13.05 | $182.12 | 2020-03-27 - 2021-03-26 | Strong Buy |
Novavax IncNVAX | +946.95% | $19.83 | $207.61 | 2020-04-24 - 2021-04-23 | Strong Buy |
Cymabay Therapeutics IncCBAY | +310.53% | $1.90 | $7.80 | 2022-05-18 - 2023-01-27 | Strong Buy |
Tg Therapeutics IncTGTX | +254.24% | $4.13 | $14.63 | 2022-06-13 - 2023-01-27 | Strong Buy |
Fortress Biotech IncFBIO | +221.05% | $1.33 | $4.27 | 2020-03-13 - 2021-03-12 | Strong Buy |
Mayank Mamtani Analyst Color
Get additional color on Mayank Mamtani's coverage of popular stocks
6 months ago
ALT
Mayank Mamtani's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Tg Therapeutics IncTGTX | 5 | Strong Buy | $23.00 | +57.21% | Maintains | a month ago |
Checkpoint Therapeutics IncCKPT | 2 | Strong Buy | $15.00 | +196.44% | Maintains | a month ago |
Vaxart IncVXRT | 3 | Hold | $1.50 | +35.14% | Maintains | a month ago |
Arrowhead Pharmaceuticals IncARWR | 3 | Strong Buy | $59.00 | +75.54% | Maintains | 2 months ago |
Spectrum Pharmaceuticals IncSPPI | 4 | Hold | $1.00 | +75.75% | Downgrades | 2 months ago |
Novavax IncNVAX | 8 | Strong Buy | $83.00 | +635.16% | Maintains | 4 months ago |
Ngm Biopharmaceuticals IncNGM | 2 | Strong Buy | $29.00 | +469.74% | Maintains | 4 months ago |
Intercept Pharmaceuticals IncICPT | 4 | Strong Buy | $28.00 | +52.17% | Maintains | 5 months ago |
Gain Therapeutics IncGANX | 3 | Hold | $5.00 | +22.85% | Downgrades | 5 months ago |
Altimmune IncALT | 2 | Strong Buy | $26.00 | +96.52% | Maintains | 6 months ago |
Cassava Sciences IncSAVA | 3 | Strong Buy | $44.00 | +52.20% | Maintains | 6 months ago |
Fortress Biotech IncFBIO | 3 | Strong Buy | $6.00 | +544.47% | Maintains | 7 months ago |
Madrigal Pharmaceuticals IncMDGL | 1 | Hold | $75.00 | -74.09% | Downgrades | 7 months ago |
Lineage Cell Therapeutics IncLCTX | 1 | Strong Buy | $4.00 | +185.71% | Initiates Coverage On | 8 months ago |
Inmune Bio IncINMB | 2 | Hold | $7.00 | -16.17% | Downgrades | 8 months ago |
X4 Pharmaceuticals IncXFOR | 2 | Strong Buy | $7.00 | +566.67% | Maintains | 8 months ago |
Cymabay Therapeutics IncCBAY | 2 | Strong Buy | $8.00 | +2.56% | Maintains | 8 months ago |
Tff Pharmaceuticals IncTFFP | 1 | Strong Buy | $18.00 | +1,804.76% | Maintains | 10 months ago |
Frequency Therapeutics IncFREQ | 1 | Strong Buy | $10.00 | +110.53% | Maintains | 10 months ago |
Allena Pharmaceuticals IncALNAQ | 3 | Hold | $0.50 | +566.67% | Downgrades | 10 months ago |
Nighthawk Biosciences IncNHWK | 1 | Strong Buy | $8.00 | +572.27% | Maintains | 10 months ago |
Seelos Therapeutics IncSEEL | 2 | Strong Buy | $4.00 | +392.61% | Maintains | a year ago |
Mustang Bio IncMBIO | 1 | Strong Buy | $6.00 | N/A | Maintains | a year ago |
Biovie IncBIVI | 1 | Strong Buy | $27.00 | N/A | Maintains | a year ago |
Eloxx Pharmaceuticals IncELOX | 1 | Strong Buy | $5.00 | N/A | Initiates Coverage On | 2 years ago |
Arcturus Therapeutics Holdings IncARCT | 2 | Hold | $77.00 | N/A | Downgrades | 2 years ago |
Acasti Pharma IncACST | 1 | Strong Buy | $2.00 | N/A | Upgrades | 3 years ago |
Galmed Pharmaceuticals LtdGLMD | 2 | Hold | $8.00 | N/A | Downgrades | 3 years ago |
Galectin Therapeutics IncGALT | 1 | Strong Buy | $4.00 | N/A | Maintains | 3 years ago |
Imv IncIMV | 1 | Hold | $3.00 | N/A | Downgrades | 3 years ago |
Liberty Media CorpFWONK | 1 | Strong Buy | $39.00 | N/A | Maintains | 3 years ago |
Medicinova IncMNOV | 1 | Strong Buy | $11.00 | N/A | Maintains | 3 years ago |
Genfit SaGNFT | 1 | Strong Buy | $34.00 | N/A | Maintains | 3 years ago |
Arqule IncARQL | 1 | Hold | $20.00 | N/A | Downgrades | 3 years ago |
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.